Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Matrix changes in articular cartilage in the knee of patients with rheumatoid arthritis after biological therapy: 1-year follow-up evaluation by T2 and T1ρ MRI quantification.

Hirose J, Nishioka H, Tsukano M, Matsubara S, Usuku K, Mizuta H.

Clin Radiol. 2018 Nov;73(11):984.e11-984.e18. doi: 10.1016/j.crad.2018.06.020. Epub 2018 Jul 30.

PMID:
30072032
2.

Efficacy and safety of olokizumab in Asian patients with moderate-to-severe rheumatoid arthritis, previously exposed to anti-TNF therapy: Results from a randomized phase II trial.

Takeuchi T, Tanaka Y, Yamanaka H, Amano K, Nagamine R, Park W, Shiozawa K, Tsukano M, Wei JC, Shao J, Togo O, Mashimo H.

Mod Rheumatol. 2016;26(1):15-23. doi: 10.3109/14397595.2015.1074648. Epub 2015 Sep 10. Erratum in: Mod Rheumatol. 2018 Sep;28(5):911-912.

PMID:
26358841
3.

Usefulness of the navigator-echo triggering technique for free-breathing three-dimensional magnetic resonance cholangiopancreatography.

Matsunaga K, Ogasawara G, Tsukano M, Iwadate Y, Inoue Y.

Magn Reson Imaging. 2013 Apr;31(3):396-400. doi: 10.1016/j.mri.2012.08.009. Epub 2012 Oct 25.

PMID:
23102944
4.

A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study.

Kameda H, Kanbe K, Sato E, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Yamanaka H, Takeuchi T; Japan Biological Agent Integrated Consortium (JBASIC).

Ann Rheum Dis. 2013 Feb;72(2):310-2. doi: 10.1136/annrheumdis-2012-201804. Epub 2012 Sep 12. No abstract available.

PMID:
22975754
5.

Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M.

Rheumatology (Oxford). 2012 Nov;51(11):2064-9. doi: 10.1093/rheumatology/kes190. Epub 2012 Aug 9.

PMID:
22879465
6.

Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR study.

Kameda H, Kanbe K, Sato E, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Yamanaka H, Takeuchi T.

J Rheumatol. 2011 Aug;38(8):1585-92. doi: 10.3899/jrheum.110014. Epub 2011 May 15.

7.

Cutaneous nodules in patients with rheumatoid arthritis: a case report and review of literatures.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Iyama K.

Clin Rheumatol. 2011 May;30(5):719-22. doi: 10.1007/s10067-010-1602-4. Epub 2010 Nov 4. Review.

PMID:
21049278
8.

Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial.

Kameda H, Ueki Y, Saito K, Nagaoka S, Hidaka T, Atsumi T, Tsukano M, Kasama T, Shiozawa S, Tanaka Y, Takeuchi T; Japan Biological Agent Study Integrated Consortium.

Mod Rheumatol. 2010 Dec;20(6):531-8. doi: 10.1007/s10165-010-0324-4. Epub 2010 Jun 24.

PMID:
20574649
9.

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M.

Clin Rheumatol. 2010 Dec;29(12):1395-401. doi: 10.1007/s10067-010-1469-4. Epub 2010 May 5.

PMID:
20440529
10.

Etanercept treatment in patients with rheumatoid arthritis on dialysis.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Arizono K, Nakamura T.

Rheumatol Int. 2010 Sep;30(11):1527-8. doi: 10.1007/s00296-010-1452-z. Epub 2010 Apr 1. No abstract available.

PMID:
20358202
11.

Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis.

Okada T, Tsukano H, Endo M, Tabata M, Miyata K, Kadomatsu T, Miyashita K, Semba K, Nakamura E, Tsukano M, Mizuta H, Oike Y.

Am J Pathol. 2010 May;176(5):2309-19. doi: 10.2353/ajpath.2010.090865. Epub 2010 Mar 19.

12.

A multicenter study of leukocytapheresis in rheumatoid arthritis.

Ueki Y, Sagawa A, Tanimura K, Yamada A, Yamamoto K, Tsuda H, Tohma S, Suzuki K, Tominaga M, Kawabe Y, Mine M, Honda S, Tsukano M, Nakamura T, Hidaka T, Eguchi K.

Clin Exp Rheumatol. 2007 Nov-Dec;25(6):810-6.

PMID:
18173913
13.

Beneficial effect of galectin 9 on rheumatoid arthritis by induction of apoptosis of synovial fibroblasts.

Seki M, Sakata KM, Oomizu S, Arikawa T, Sakata A, Ueno M, Nobumoto A, Niki T, Saita N, Ito K, Dai SY, Katoh S, Nishi N, Tsukano M, Ishikawa K, Yamauchi A, Kuchroo V, Hirashima M.

Arthritis Rheum. 2007 Dec;56(12):3968-76.

14.

Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S.

Clin Exp Rheumatol. 2007 Jul-Aug;25(4):518-22. Erratum in: Clin Exp Rheumatol. 2007 Sep-Oct;25(5):798.

PMID:
17888205
15.

CD8+ T lymphocytes infiltrate predominantly in the inflammatory foci of MPO-ANCA-positive thoracic hypertrophic pachymeningitis in a patient with HLA-A24.

Nakamura T, Hirakawa K, Higashi S, Tomoda K, Tsukano M, Iyama K, Sakae T.

Mod Rheumatol. 2007;17(1):75-80. Epub 2007 Feb 20. Review.

PMID:
17278028
16.

A study of ten Japanese patients with seronegative spondylarthropathy: a tentative proposal.

Higashi S, Nakamura T, Tomoda K, Tsukano M, Sakaguchi M, Kuga F.

Mod Rheumatol. 2005;15(5):329-35.

PMID:
17029088
17.

Primary biliary cirrhosis (PBC)-CREST overlap syndrome with coexistence of Sjögren's syndrome and thyroid dysfunction.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Sugi K.

Clin Rheumatol. 2007 Apr;26(4):596-600. Epub 2006 Feb 22.

PMID:
16496080
18.

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Higashi S, Tomoda K, Tsukano M, Baba S, Shono M.

Rheumatology (Oxford). 2006 Jan;45(1):43-9. Epub 2005 Oct 11.

PMID:
16219644
19.

Gustatory sweating due to autonomic neuropathy in a patient with amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Tomoda K, Tsukano M, Yamamura Y, Baba S.

Mod Rheumatol. 2004 Dec;14(6):498-501. doi: 10.3109/s10165-004-0349-7.

PMID:
24387731
20.

Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.

Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S.

Clin Rheumatol. 2003 Dec;22(6):371-5. Epub 2003 Nov 7.

PMID:
14677008
21.

Massive hematuria due to bladder amyloidosis in patients with rheumatoid arthritis: three case reports.

Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Baba S.

Clin Exp Rheumatol. 2003 Sep-Oct;21(5):673-4. No abstract available.

PMID:
14611124
22.

Polyarteritis nodosa limited to calf muscles: a case report and review of the literature.

Nakamura T, Tomoda K, Yamamura Y, Tsukano M, Honda I, Iyama K.

Clin Rheumatol. 2003 May;22(2):149-53. Review.

PMID:
12740683
23.

Mycobacterium kansasii arthritis of the foot in a patient with systemic lupus erythematosus.

Nakamura T, Yamamura Y, Tsuruta T, Tomoda K, Sakaguchi M, Tsukano M.

Intern Med. 2001 Oct;40(10):1045-9. Review.

24.

[Clinical study on mortality of rheumatoid arthritis compared with malignant rheumatoid arthritis].

Nanamura T, Yamamura Y, Tsuruta T, Tomoda K, Sakaguchi M, Tsukano M, Shono M.

Ryumachi. 2001 Aug;41(4):736-44. Japanese.

PMID:
11577402
25.

Combined treatment with cyclophosphamide and prednisolone is effective for secondary amyloidosis with SAA1γ/γ genotype in a patient with rheumatoid arthritis.

Nakamura T, Baba S, Yamamura Y, Tsuruta T, Matsubara S, Tomoda K, Tsukano M.

Mod Rheumatol. 2000 Sep;10(3):160-4. doi: 10.3109/s101650070024.

PMID:
24383594
26.

Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis.

Nakashima-Matsushita N, Homma T, Yu S, Matsuda T, Sunahara N, Nakamura T, Tsukano M, Ratnam M, Matsuyama T.

Arthritis Rheum. 1999 Aug;42(8):1609-16.

27.

Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts.

Yu S, Nakashima N, Xu BH, Matsuda T, Izumihara A, Sunahara N, Nakamura T, Tsukano M, Matsuyama T.

Rheumatol Int. 1998;17(6):237-43.

PMID:
9592864
28.

[Crescentic glomerulonephritis in a patient with rheumatoid arthritis].

Nakamura T, Arima S, Tsuruta T, Matsubara S, Sakaguchi M, Wakamatsu S, Tomita K, Tsukano M.

Ryumachi. 1997 Jun;37(3):476-82. Japanese.

PMID:
9256031
29.

IL-8/NAP-1 is the major T-cell chemoattractant in synovial tissues of rheumatoid arthritis.

Nishiura H, Tanaka J, Takeya M, Tsukano M, Kambara T, Imamura T.

Clin Immunol Immunopathol. 1996 Aug;80(2):179-84.

PMID:
8764563
31.

Effect of testosterone on the kinetics of the development of suppressor cells in adjuvant arthritis.

Tsukano M, Kotani M, Matsuno K, Miyakawa K, Nawa Y.

Experientia. 1985 Oct 15;41(10):1337-8.

PMID:
2931302
32.

Characterization of low dose induced suppressor cells in adjuvant arthritis in rats.

Tsukano M, Nawa Y, Kotani M.

Clin Exp Immunol. 1983 Jul;53(1):60-6.

33.

[Binocular infrared videopupillography (author's transl)].

Tsukano M, Hirata E, Kimura T, Utsumi T, Ishikawa S.

Nippon Ganka Gakkai Zasshi. 1976 Sep 10;80(9):946-51. Japanese. No abstract available.

PMID:
1035054

Supplemental Content

Loading ...
Support Center